Yao has over a decade of experience deploying innovative approaches to develop small molecule modulators against novel targets in neurodegenerative, metabolic, cancer, and other age-related diseases. Prior to joining Interline, he was a Project Team Leader at Calico Life Sciences, where he was accountable for leading programs from lead generation into early clinical development. Yao earned a B.Sc. in Biochemistry from the University of Toronto, and a Ph.D. in Biochemistry/Biophysics from Northwestern University. He completed postdoctoral training at the Ludwig Institute for Cancer Research, UC San Diego.
When Yao isn’t obsessing over science, he spends his time alternately hunting for the best food around the world with his family and running to work off the calories.